相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genetic correlations of polygenic disease traits: from theory to practice
Wouter van Rheenen et al.
NATURE REVIEWS GENETICS (2019)
Inferring Causal Relationships Between Risk Factors and Outcomes from Genome-Wide Association Study Data
Stephen Burgess et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 19 (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger RegressionBrief Report
Christopher Labos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records
QiPing Feng et al.
PLOS MEDICINE (2018)
Safety and efficacy of statin therapy
Bhavin B. Adhyaru et al.
NATURE REVIEWS CARDIOLOGY (2018)
LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis
Jie Zheng et al.
BIOINFORMATICS (2017)
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
Fernando Pires Hartwig et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Exome-wide association study of plasma lipids in >300,000 individuals
Dajiang J. Liu et al.
NATURE GENETICS (2017)
A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization
Jack Bowden et al.
STATISTICS IN MEDICINE (2017)
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
Amand F. Schmidt et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization
Suzanne H. Gage et al.
SCIENTIFIC REPORTS (2017)
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans
Robert A. Scott et al.
DIABETES (2017)
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
Jack Bowden et al.
GENETIC EPIDEMIOLOGY (2016)
Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes A Meta-analysis
Luca A. Lotta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Brian A. Ference et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes
Jon White et al.
JAMA CARDIOLOGY (2016)
Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects
Stephen Burgess et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes
Tove Fall et al.
DIABETES (2015)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Joost Besseling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow et al.
LANCET (2015)
An atlas of genetic correlations across human diseases and traits
Brendan Bulik-Sullivan et al.
NATURE GENETICS (2015)
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
Brendan K. Bulik-Sullivan et al.
NATURE GENETICS (2015)
Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (<30 mg/dl) With Rosuvastatin 20 mg Daily (from JUPITER)
Brendan M. Everett et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
Iris Postmus et al.
NATURE COMMUNICATIONS (2014)
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
Eliano Pio Navarese et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators
Brandon L. Pierce et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Stephen Burgess et al.
GENETIC EPIDEMIOLOGY (2013)
Use of allele scores as instrumental variables for Mendelian randomization
Stephen Burgess et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
Andrew P. Morris et al.
NATURE GENETICS (2012)
Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis
Gerta Ruecker et al.
BIOSTATISTICS (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
Judith Hsia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Association of the CHRNA5-A3-B4 Gene Cluster With Heaviness of Smoking: A Meta-Analysis
Jennifer J. Ware et al.
NICOTINE & TOBACCO RESEARCH (2011)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)